IRTC
iRhythm Holdings, Inc.
Company overview
- Market capitalization
- $3.71B
- Employees
- 2,400
- Latest publication
- 2026-09-29
About iRhythm Holdings, Inc.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20252025-12-31 · USD |
|---|---|---|
| Total Revenue | 224,172,000USD | 208,890,000USD |
| Cost Of Revenue | 60,967,000USD | 60,835,000USD |
| Gross Profit | 163,205,000USD | 148,055,000USD |
| Selling General Administrative | 131,655,000USD | 122,004,000USD |
| Total Operating Expenses | 165,747,000USD | 139,288,000USD |
| Operating Income | -2,542,000USD | 8,767,000USD |
| Total Other Income Expense Net | 2,161,000USD | -2,741,000USD |
| Interest Income | 4,776,000USD | 5,337,000USD |
| Interest Expense | 3,294,000USD | 3,322,000USD |
| Litigation Settlement Expense | 13,950,000USD | — |
| Income Before Tax | -381,000USD | 6,026,000USD |
| Income Tax Expense | 0USD | 447,000USD |
| Net Income | -381,000USD | 5,579,000USD |
| Research Development | — | 21,046,000USD |
| Unclassified Operating Expenses | — | -3,762,000USD |
| Net Interest Income | — | 2,015,000USD |
| Tax Provision | — | 447,000USD |
| Net Income From Continuing Ops | — | 5,579,000USD |
| Ebit | — | 9,348,000USD |
| Ebitda | — | 16,075,000USD |
| Depreciation And Amortization | — | 6,727,000USD |
| Reconciled Depreciation | — | 6,727,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,093,426,000USD | 1,006,365,000USD | 1,020,042,000USD | 995,214,000USD | 964,030,000USD | 926,098,000USD | 931,449,000USD | 909,688,000USD |
| Cash And Equivalents | 246,679,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 591,274,000USD | 549,620,000USD | 583,763,000USD | 565,213,000USD | 545,540,000USD | 520,589,000USD | 535,553,000USD | 522,031,000USD |
| Short Term Investments | 344,595,000USD | 309,474,000USD | 347,751,000USD | 309,608,000USD | 236,435,000USD | 145,311,000USD | 115,956,000USD | 2,496,000USD |
| Long Term Investments | 73,682,000USD | 72,860,000USD | 69,913,000USD | 68,091,000USD | 64,897,000USD | 62,745,000USD | 61,902,000USD | 59,059,000USD |
| Total Current Assets | 755,954,000USD | 680,558,000USD | 702,765,000USD | 680,035,000USD | 663,917,000USD | 636,013,000USD | 645,819,000USD | 627,909,000USD |
| Other Current Assets | 57,893,000USD | 26,275,000USD | 21,662,000USD | 19,106,000USD | 17,825,000USD | 20,449,000USD | 16,286,000USD | 13,419,000USD |
| Other Non Current Assets | 50,468,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 907,443,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 196,098,000USD | 131,750,000USD | 151,890,000USD | 146,910,000USD | 132,211,000USD | 111,344,000USD | 110,920,000USD | 100,104,000USD |
| Other Current Liabilities | 157,570,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 908,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 185,983,000USD | 161,210,000USD | 152,746,000USD | 121,893,000USD | 103,660,000USD | 86,665,000USD | 90,908,000USD | 71,766,000USD |
| Total Equity Including Noncontrolling Interest | 185,983,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 4,205,000USD | — | — | — | — | — | — | — |
| Net Receivables | 84,274,000USD | 80,863,000USD | 75,706,000USD | 76,157,000USD | 82,153,000USD | 80,639,000USD | 79,941,000USD | 77,427,000USD |
| Inventory | 22,513,000USD | 23,800,000USD | 21,634,000USD | 19,559,000USD | 18,399,000USD | 14,336,000USD | 14,039,000USD | 15,032,000USD |
| Property Plant Equipment Net | 204,102,000USD | 197,028,000USD | 193,426,000USD | 192,616,000USD | 184,452,000USD | 177,021,000USD | 172,656,000USD | 167,960,000USD |
| Goodwill | 862,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 17,411,000USD | 8,559,000USD | 2,256,000USD | 8,278,000USD | 12,775,000USD | 11,946,000USD | 7,221,000USD | 7,593,000USD |
| Short Term Debt | 16,912,000USD | 16,793,000USD | 16,686,000USD | 16,526,000USD | 16,360,000USD | 16,140,000USD | 15,867,000USD | 15,522,000USD |
| Common Stock | 33,000USD | 33,000USD | 32,000USD | 32,000USD | 32,000USD | 32,000USD | 31,000USD | 31,000USD |
| Retained Earnings | -817,760,000USD | -817,379,000USD | -803,446,000USD | -809,025,000USD | -803,813,000USD | -789,595,000USD | -758,895,000USD | -757,562,000USD |
| Accumulated Other Comprehensive Income | -188,000USD | 42,000USD | 403,000USD | 285,000USD | -26,000USD | 143,000USD | 165,000USD | -66,000USD |
| Total Liab | — | 845,155,000USD | 867,296,000USD | 873,321,000USD | 860,370,000USD | 839,433,000USD | 840,541,000USD | 837,922,000USD |
| Other Current Liab | — | 102,342,000USD | 128,747,000USD | 117,882,000USD | 97,325,000USD | 79,976,000USD | 80,892,000USD | 70,296,000USD |
| Capital Stock | — | 33,000USD | 32,000USD | 32,000USD | 32,000USD | 32,000USD | 31,000USD | 31,000USD |
| Good Will | — | 862,000USD | 862,000USD | 862,000USD | 862,000USD | 862,000USD | 862,000USD | 862,000USD |
| Cash | — | 240,146,000USD | 236,012,000USD | 255,605,000USD | 309,105,000USD | 375,278,000USD | 419,597,000USD | 519,535,000USD |
| Current Deferred Revenue | — | 4,056,000USD | 4,201,000USD | 4,224,000USD | 3,499,000USD | 3,282,000USD | 2,932,000USD | 3,031,000USD |
| Net Debt | — | 489,145,000USD | 495,172,000USD | 477,406,000USD | 425,639,000USD | 360,224,000USD | 317,312,000USD | 215,827,000USD |
| Short Long Term Debt Total | — | 729,291,000USD | 731,184,000USD | 733,011,000USD | 734,744,000USD | 735,502,000USD | 736,909,000USD | 735,362,000USD |
| Long Term Debt | — | 650,313,000USD | 649,504,000USD | 648,753,000USD | 648,007,000USD | 647,237,000USD | 646,443,000USD | 645,821,000USD |
| Property Plant Equipment Gross | — | 293,262,000USD | 284,618,000USD | 278,803,000USD | 265,466,000USD | 252,930,000USD | 243,875,000USD | 233,890,000USD |
| Common Stock Shares Outstanding | — | 32,507,000shares | 33,332,000shares | 32,170,000shares | 31,990,000shares | 31,590,000shares | 31,343,000shares | 31,262,000shares |
| Non Current Assets Total | — | 325,807,000USD | 317,277,000USD | 315,179,000USD | 300,113,000USD | 290,085,000USD | 285,630,000USD | 281,779,000USD |
| Non Current Liabilities Total | — | 713,405,000USD | 715,406,000USD | 726,411,000USD | 728,159,000USD | 728,089,000USD | 729,621,000USD | 737,818,000USD |
| Non Current Liabilities Other | — | 907,000USD | 908,000USD | 9,926,000USD | 9,775,000USD | 8,727,000USD | 8,579,000USD | 17,978,000USD |
| Non Currrent Assets Other | — | 55,057,000USD | 53,076,000USD | 53,610,000USD | 49,902,000USD | 49,457,000USD | 50,210,000USD | 53,898,000USD |
| Net Working Capital | — | 548,808,000USD | 550,875,000USD | 533,125,000USD | 531,706,000USD | 524,669,000USD | 534,899,000USD | 527,805,000USD |
| Unclassified Non Current Liabilities | — | 62,185,000USD | 64,994,000USD | 67,732,000USD | 70,377,000USD | 72,125,000USD | 74,599,000USD | 74,019,000USD |
| Unclassified Equity | — | 978,481,000USD | 955,725,000USD | 930,569,000USD | 907,435,000USD | 876,053,000USD | 849,576,000USD | 829,332,000USD |
| Unclassified Current Liabilities | — | — | — | — | 2,252,000USD | — | 4,008,000USD | 3,662,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,020,042,000USD | 931,449,000USD | 433,144,000USD | 448,222,000USD | 462,967,000USD | 511,739,000USD | 306,212,000USD | 119,710,000USD |
| Other Current Assets | 21,662,000USD | 16,286,000USD | 21,591,000USD | 10,555,000USD | 9,693,000USD | 7,363,000USD | 4,337,000USD | 8,200,000USD |
| Total Liab | 867,296,000USD | 840,541,000USD | 223,047,000USD | 208,410,000USD | 183,452,000USD | 170,127,000USD | 170,803,000USD | 65,288,000USD |
| Total Stockholder Equity | 152,746,000USD | 90,908,000USD | 210,097,000USD | 239,812,000USD | 279,515,000USD | 341,612,000USD | 135,409,000USD | 54,422,000USD |
| Other Current Liab | 128,747,000USD | 80,892,000USD | 80,485,000USD | 63,109,000USD | 51,486,000USD | 40,532,000USD | 32,714,000USD | 26,827,000USD |
| Common Stock | 32,000USD | 31,000USD | 31,000USD | 28,000USD | 27,000USD | 27,000USD | 25,000USD | 23,000USD |
| Capital Stock | 32,000USD | 31,000USD | 31,000USD | 28,000USD | 27,000USD | 27,000USD | 25,000USD | 23,000USD |
| Retained Earnings | -803,446,000USD | -758,895,000USD | -645,606,000USD | -522,200,000USD | -406,045,000USD | -304,684,000USD | -260,393,000USD | -203,515,000USD |
| Good Will | 862,000USD | 862,000USD | 862,000USD | 862,000USD | 862,000USD | 862,000USD | 862,000USD | 862,000USD |
| Cash | 236,012,000USD | 419,597,000USD | 36,173,000USD | 78,832,000USD | 127,562,000USD | 88,628,000USD | 20,462,000USD | 20,023,000USD |
| Cash And Short Term Investments | 583,763,000USD | 535,553,000USD | 133,764,000USD | 213,144,000USD | 239,131,000USD | 335,217,000USD | 140,551,000USD | 78,343,000USD |
| Total Current Assets | 702,765,000USD | 645,819,000USD | 230,812,000USD | 288,772,000USD | 305,522,000USD | 377,825,000USD | 172,792,000USD | 106,482,000USD |
| Total Current Liabilities | 151,890,000USD | 110,920,000USD | 107,370,000USD | 89,096,000USD | 87,853,000USD | 65,665,000USD | 52,066,000USD | 30,236,000USD |
| Current Deferred Revenue | 4,201,000USD | 2,932,000USD | 3,306,000USD | 3,051,000USD | 3,049,000USD | 930,000USD | 1,251,000USD | 1,243,000USD |
| Net Debt | 495,172,000USD | 317,312,000USD | 93,651,000USD | 52,206,000USD | -9,851,000USD | 33,842,000USD | 108,133,000USD | 14,876,000USD |
| Short Term Debt | 16,686,000USD | 15,867,000USD | 15,159,000USD | 13,031,000USD | 22,809,000USD | 19,838,000USD | 9,858,000USD | — |
| Short Long Term Debt Total | 731,184,000USD | 736,909,000USD | 129,824,000USD | 131,038,000USD | 117,711,000USD | 122,470,000USD | 128,595,000USD | 34,899,000USD |
| Long Term Debt | 649,504,000USD | 646,443,000USD | 34,950,000USD | 34,935,000USD | 9,690,000USD | 21,339,000USD | 32,989,000USD | 34,899,000USD |
| Long Term Investments | 69,913,000USD | 61,902,000USD | 3,000,000USD | — | — | 0USD | 8,030,000USD | 0USD |
| Short Term Investments | 347,751,000USD | 115,956,000USD | 97,591,000USD | 134,312,000USD | 111,569,000USD | 246,589,000USD | 120,089,000USD | 58,320,000USD |
| Net Receivables | 75,706,000USD | 79,941,000USD | 61,484,000USD | 49,918,000USD | 46,430,000USD | 29,932,000USD | 23,867,000USD | 19,790,000USD |
| Inventory | 21,634,000USD | 14,039,000USD | 13,973,000USD | 15,155,000USD | 10,268,000USD | 5,313,000USD | 4,037,000USD | 2,062,000USD |
| Accounts Payable | 2,256,000USD | 7,221,000USD | 5,543,000USD | 7,517,000USD | 10,509,000USD | 4,365,000USD | 8,243,000USD | 2,284,000USD |
| Property Plant Equipment Net | 193,426,000USD | 172,656,000USD | 153,431,000USD | 136,336,000USD | 140,531,000USD | 118,961,000USD | 116,588,000USD | 9,158,000USD |
| Property Plant Equipment Gross | 284,618,000USD | 243,875,000USD | 203,934,000USD | 136,336,000USD | 140,531,000USD | 118,961,000USD | 116,588,000USD | 9,158,000USD |
| Accumulated Other Comprehensive Income | 403,000USD | 165,000USD | -112,000USD | -396,000USD | -61,000USD | 11,000USD | 82,000USD | -41,000USD |
| Common Stock Shares Outstanding | 32,003,999shares | 31,196,000shares | 30,528,000shares | 29,915,720shares | 29,331,010shares | 27,754,404shares | 25,265,918shares | 23,885,858shares |
| Non Current Assets Total | 317,277,000USD | 285,630,000USD | 202,332,000USD | 159,450,000USD | 157,445,000USD | 133,914,000USD | 133,420,000USD | 13,228,000USD |
| Non Current Liabilities Total | 715,406,000USD | 729,621,000USD | 115,677,000USD | 119,314,000USD | 95,599,000USD | 104,462,000USD | 118,737,000USD | 35,052,000USD |
| Non Current Liabilities Other | 908,000USD | 8,579,000USD | 1,012,000USD | 1,307,000USD | 697,000USD | 83,123,000USD | 85,748,000USD | — |
| Non Currrent Assets Other | 53,076,000USD | 50,210,000USD | 45,039,000USD | 22,252,000USD | 16,052,000USD | 14,091,000USD | 7,940,000USD | 3,208,000USD |
| Net Working Capital | 550,875,000USD | 534,899,000USD | 123,442,000USD | 199,676,000USD | 217,669,000USD | 312,160,000USD | 120,726,000USD | 76,246,000USD |
| Unclassified Non Current Liabilities | 64,994,000USD | 74,599,000USD | 79,715,000USD | 81,765,000USD | 84,515,000USD | -1,830,000USD | — | — |
| Unclassified Equity | 955,725,000USD | 849,576,000USD | 855,753,000USD | 762,352,000USD | 685,567,000USD | 646,231,000USD | 395,670,000USD | 257,932,000USD |
| Unclassified Current Liabilities | — | 4,008,000USD | 2,877,000USD | 2,388,000USD | -11,667,000USD | -11,667,000USD | -1,944,000USD | — |
| Other Liab | — | — | — | 1,307,000USD | 697,000USD | 1,830,000USD | — | 153,000USD |
| Other Assets | — | — | — | 22,252,000USD | 16,052,000USD | 98,805,000USD | 7,940,000USD | 3,208,000USD |
| Net Tangible Assets | — | — | — | 238,950,000USD | 278,653,000USD | 340,750,000USD | 134,547,000USD | 51,275,000USD |
| Unclassified Non Current Assets | — | — | — | -22,252,000USD | -16,052,000USD | -98,805,000USD | -7,940,000USD | -3,208,000USD |
| Short Long Term Debt | — | — | — | — | 11,667,000USD | 11,667,000USD | 1,944,000USD | — |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 153,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -1,913,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -13,933,000USD | 5,579,000USD | -5,212,000USD | -14,218,000USD | -30,700,000USD | -1,333,000USD | -46,182,000USD | -20,107,000USD |
| Depreciation | 4,312,000USD | 6,727,000USD | 6,621,000USD | 4,451,000USD | 4,591,000USD | 6,604,000USD | 1,415,000USD | 6,400,000USD |
| Stock Based Compensation | 21,491,000USD | 21,106,000USD | 21,006,000USD | 22,827,000USD | 23,344,000USD | 16,008,000USD | 17,158,000USD | 21,821,000USD |
| Other Non Cash Items | 29,345,000USD | 20,195,000USD | 25,509,000USD | 29,564,000USD | 31,410,000USD | 20,909,000USD | -21,698,000USD | 19,998,000USD |
| Change To Account Receivables | -33,000,000USD | -19,054,000USD | -19,461,000USD | -26,791,000USD | -30,125,000USD | -23,240,000USD | -9,164,000USD | -14,998,000USD |
| Change To Inventory | -2,424,000USD | -2,062,000USD | -1,849,000USD | -4,213,000USD | -388,000USD | 817,000USD | 425,000USD | -543,000USD |
| Change In Working Capital | -67,388,000USD | -27,395,000USD | -13,041,000USD | -14,965,000USD | -36,536,000USD | -22,956,000USD | 73,654,000USD | -16,272,000USD |
| Total Cash From Operating Activities | -26,173,000USD | 26,212,000USD | 34,883,000USD | 27,659,000USD | -7,891,000USD | 19,232,000USD | 24,347,000USD | 11,840,000USD |
| Capital Expenditures | -6,905,000USD | -11,723,000USD | -14,831,000USD | -10,369,000USD | -9,419,000USD | -6,844,000USD | -8,834,000USD | -8,488,000USD |
| Free Cash Flow | -33,078,000USD | 14,489,000USD | 20,052,000USD | 17,290,000USD | -17,310,000USD | 12,388,000USD | 15,513,000USD | 3,352,000USD |
| Investments | 37,120,000USD | -37,075,000USD | -89,204,000USD | -100,915,000USD | -38,139,000USD | -122,159,000USD | -55,334,000USD | 14,512,000USD |
| Total Cashflows From Investing Activities | 30,215,000USD | -48,798,000USD | -89,204,000USD | -100,915,000USD | -38,139,000USD | -122,159,000USD | -55,334,000USD | 14,512,000USD |
| Total Cash From Financing Activities | 149,000USD | 2,959,000USD | 825,000USD | 7,094,000USD | 1,729,000USD | 2,987,000USD | -35,000USD | 3,788,000USD |
| Change In Cash | 4,134,000USD | -19,593,000USD | -53,500,000USD | -66,173,000USD | -44,319,000USD | -99,937,999USD | -31,017,000USD | 30,131,000USD |
| Begin Period Cash Flow | 244,370,000USD | 263,963,000USD | 317,463,000USD | 383,636,000USD | 427,955,000USD | 519,534,999USD | 558,910,000USD | 520,421,000USD |
| End Period Cash Flow | 248,504,000USD | 244,370,000USD | 263,963,000USD | 317,463,000USD | 383,636,000USD | 419,597,000USD | 527,893,000USD | 550,552,000USD |
| Other Cashflows From Financing Activities | 149,000USD | — | 825,000USD | — | 1,729,000USD | 597,643,000USD | 148,000USD | 3,788,000USD |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Sale Purchase Of Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 25,000,000USD | 0USD |
| Unclassified Financing Cash Flow | — | 2,959,000USD | — | 7,094,000USD | — | -594,656,000USD | -25,183,000USD | — |
| Unclassified Investing Cash Flow | — | — | 14,831,000USD | 10,369,000USD | 9,419,000USD | 6,844,000USD | 23,834,000USD | -14,512,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | -15,000,000USD | 23,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -44,551,000USD | -113,289,000USD | -123,406,000USD | -116,155,000USD | -101,361,000USD | -43,830,000USD | -54,568,000USD | -48,280,000USD |
| Depreciation | 26,479,000USD | 25,777,000USD | 22,144,000USD | 19,609,000USD | 16,594,000USD | 6,900,000USD | 3,445,000USD | 2,269,000USD |
| Stock Based Compensation | 88,283,000USD | 75,978,000USD | 77,204,000USD | 57,740,000USD | 54,527,000USD | 41,515,000USD | 26,241,000USD | 16,329,000USD |
| Other Non Cash Items | 102,349,000USD | 102,506,000USD | 76,003,000USD | 81,303,000USD | 38,715,000USD | 6,030,000USD | 8,990,000USD | -2,931,000USD |
| Change To Account Receivables | -95,431,000USD | -91,920,000USD | -81,193,000USD | -61,837,000USD | -53,572,000USD | -37,957,000USD | -28,725,000USD | -22,885,000USD |
| Change To Inventory | -8,512,000USD | -224,000USD | 979,000USD | -5,108,000USD | -4,960,000USD | -1,389,000USD | -1,974,000USD | -380,000USD |
| Change In Working Capital | -91,697,000USD | -99,116,000USD | -102,046,000USD | -65,509,000USD | -46,228,000USD | -56,235,000USD | -29,734,000USD | -13,870,000USD |
| Total Cash From Operating Activities | 80,863,000USD | 3,390,000USD | -50,101,000USD | -23,012,000USD | -37,753,000USD | -13,759,000USD | -21,863,000USD | -29,068,000USD |
| Capital Expenditures | -46,342,000USD | -33,942,000USD | -40,424,000USD | -29,830,000USD | -28,066,999USD | -13,551,000USD | -20,457,000USD | -5,180,000USD |
| Free Cash Flow | 34,521,000USD | -30,552,000USD | -90,525,000USD | -52,842,000USD | -65,819,999USD | -27,310,000USD | -42,320,000USD | -34,248,000USD |
| Investments | -230,714,000USD | -122,983,000USD | -10,723,000USD | -22,604,000USD | 133,331,000USD | -118,840,000USD | -68,817,000USD | 39,297,000USD |
| Total Cashflows From Investing Activities | -277,056,000USD | -122,983,000USD | -1,209,000USD | -52,434,000USD | 105,264,000USD | -132,391,000USD | -89,274,000USD | 34,117,000USD |
| Net Borrowings | 0USD | 619,839,000USD | 0USD | 13,534,000USD | -11,667,000USD | -1,944,000USD | -1,944,000USD | 861,000USD |
| Total Cash From Financing Activities | 12,607,000USD | 511,381,000USD | 8,820,000USD | 26,716,000USD | -28,577,000USD | 214,316,000USD | 111,576,000USD | 6,303,000USD |
| Sale Purchase Of Stock | 0USD | -25,000,000USD | 0USD | 13,182,000USD | -25,853,000USD | -10,009,000USD | -5,288,000USD | -3,877,000USD |
| Change In Cash | -183,585,000USD | 391,782,000USD | -42,659,000USD | -48,730,000USD | 38,934,000USD | 68,166,000USD | 439,000USD | 11,352,000USD |
| Begin Period Cash Flow | 419,597,000USD | 36,173,000USD | 78,832,000USD | 127,562,000USD | 88,628,000USD | 20,462,000USD | 20,023,000USD | 8,671,000USD |
| End Period Cash Flow | 236,012,000USD | 427,955,000USD | 36,173,000USD | 78,832,000USD | 127,562,000USD | 88,628,000USD | 20,462,000USD | 20,023,000USD |
| Other Cashflows From Investing Activities | -277,056,000USD | -89,041,000USD | — | -52,434,000USD | 133,331,000USD | -118,840,000USD | -68,817,000USD | 39,322,000USD |
| Other Cashflows From Financing Activities | 12,607,000USD | -83,458,000USD | 8,820,000USD | 13,182,000USD | -25,853,000USD | 10,235,000USD | 4,207,000USD | 2,803,000USD |
| Unclassified Investing Cash Flow | 277,056,000USD | 122,983,000USD | 49,938,000USD | 52,434,000USD | -133,331,001USD | 118,840,000USD | 68,817,000USD | -39,322,000USD |
| Unclassified Operating Cash Flow | — | 11,534,000USD | — | — | — | 31,861,000USD | 23,763,000USD | 17,415,000USD |
| Change To Liabilities | — | — | — | 11,480,000USD | 8,254,000USD | -2,573,000USD | 11,606,000USD | 10,584,000USD |
| Issuance Of Capital Stock | — | — | — | 0USD | -362,000USD | 206,025,000USD | 116,864,000USD | 0USD |
| Cash And Cash Equivalents Changes | — | — | — | -48,730,000USD | — | 68,166,000USD | 439,000USD | 11,352,000USD |
| Unclassified Financing Cash Flow | — | — | — | -13,182,000USD | 60,649,000USD | 226,043,000USD | 114,601,000USD | 6,516,000USD |
| Dividends Paid | — | — | — | — | -25,853,000USD | -10,009,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Centers For Medicare Medicaid Services | 58,550,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Commercial Payors | 113,783,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Healthcare Institutions | 37,782,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Non Contracted Third Party Payors | 14,057,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Centers For Medicare Medicaid Services | 51,389,000 | USD | 0001388658-26-000039 |
| Q1 2026Quarterly · 2026-03-31 | Product | Commercial Payors | 106,804,000 | USD | 0001388658-26-000039 |
| Q1 2026Quarterly · 2026-03-31 | Product | Healthcare Institutions | 30,154,000 | USD | 0001388658-26-000039 |
| Q1 2026Quarterly · 2026-03-31 | Product | Non Contracted Third Party Payors | 11,043,000 | USD | 0001388658-26-000039 |
| Q4 2025Quarterly · 2025-12-31 | Product | Centers For Medicare And Medicaid | 49,193,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Commercial Payors | 111,699,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Healthcare Institutions | 34,319,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Non Contracted Third Party Payors | 13,679,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Centers For Medicare And Medicaid | 179,350,000 | USD | 0001388658-26-000011 |
| FY 2025Yearly · 2025-12-31 | Product | Commercial Payors | 392,234,000 | USD | 0001388658-26-000011 |
| FY 2025Yearly · 2025-12-31 | Product | Healthcare Institutions | 125,613,000 | USD | 0001388658-26-000011 |
| FY 2025Yearly · 2025-12-31 | Product | Non Contracted Third Party Payors | 49,941,000 | USD | 0001388658-26-000011 |
| Q3 2025Quarterly · 2025-09-30 | Product | Centers For Medicare And Medicaid | 47,564,000 | USD | 0001388658-25-000217 |
| Q3 2025Quarterly · 2025-09-30 | Product | Commercial Payors | 99,014,000 | USD | 0001388658-25-000217 |
| Q3 2025Quarterly · 2025-09-30 | Product | Healthcare Institutions | 32,791,000 | USD | 0001388658-25-000217 |
| Q3 2025Quarterly · 2025-09-30 | Product | Non Contracted Third Party Payors | 13,515,000 | USD | 0001388658-25-000217 |
| Q2 2025Quarterly · 2025-06-30 | Product | Centers For Medicare And Medicaid | 44,481,000 | USD | 0001388658-25-000196 |
| Q2 2025Quarterly · 2025-06-30 | Product | Commercial Payors | 97,719,000 | USD | 0001388658-25-000196 |
| Q2 2025Quarterly · 2025-06-30 | Product | Healthcare Institutions | 31,830,000 | USD | 0001388658-25-000196 |
| Q2 2025Quarterly · 2025-06-30 | Product | Non Contracted Third Party Payors | 12,657,000 | USD | 0001388658-25-000196 |
| Q1 2025Quarterly · 2025-03-31 | Product | Centers For Medicare Medicaid Services | 38,112,000 | USD | 0001388658-26-000039 |
| Q1 2025Quarterly · 2025-03-31 | Product | Commercial Payors | 83,802,000 | USD | 0001388658-26-000039 |
| Q1 2025Quarterly · 2025-03-31 | Product | Healthcare Institutions | 26,673,000 | USD | 0001388658-26-000039 |
| Q1 2025Quarterly · 2025-03-31 | Product | Non Contracted Third Party Payors | 10,090,000 | USD | 0001388658-26-000039 |
| Q4 2024Quarterly · 2024-12-31 | Product | Centers For Medicare And Medicaid | 38,338,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Commercial Payors | 83,320,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Healthcare Institutions | 29,846,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Non Contracted Third Party Payors | 12,821,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Centers For Medicare And Medicaid | 142,389,000 | USD | 0001388658-26-000011 |
| FY 2024Yearly · 2024-12-31 | Product | Commercial Payors | 311,605,000 | USD | 0001388658-26-000011 |
| FY 2024Yearly · 2024-12-31 | Product | Healthcare Institutions | 95,115,000 | USD | 0001388658-26-000011 |
| FY 2024Yearly · 2024-12-31 | Product | Non Contracted Third Party Payors | 42,730,000 | USD | 0001388658-26-000011 |
| Q3 2024Quarterly · 2024-09-30 | Product | Centers For Medicare And Medicaid | 36,011,000 | USD | 0001388658-25-000217 |
| Q3 2024Quarterly · 2024-09-30 | Product | Commercial Payors | 77,257,000 | USD | 0001388658-25-000217 |
| Q3 2024Quarterly · 2024-09-30 | Product | Healthcare Institutions | 23,461,000 | USD | 0001388658-25-000217 |
| Q3 2024Quarterly · 2024-09-30 | Product | Non Contracted Third Party Payors | 10,809,000 | USD | 0001388658-25-000217 |
| FY 2023Yearly · 2023-12-31 | Product | Centers For Medicare And Medicaid | 122,414,000 | USD | 0001388658-26-000011 |
| FY 2023Yearly · 2023-12-31 | Product | Commercial Payors | 267,195,000 | USD | 0001388658-26-000011 |
| FY 2023Yearly · 2023-12-31 | Product | Healthcare Institutions | 71,001,000 | USD | 0001388658-26-000011 |
| FY 2023Yearly · 2023-12-31 | Product | Non Contracted Third Party Payors | 32,071,000 | USD | 0001388658-26-000011 |
| FY 2022Yearly · 2022-12-31 | Product | Centers For Medicare And Medicaid | 103,032,000 | USD | 0001388658-25-000028 |
| FY 2022Yearly · 2022-12-31 | Product | Commercial Payors | 223,984,000 | USD | 0001388658-25-000028 |
| FY 2022Yearly · 2022-12-31 | Product | Healthcare Institutions | 59,772,000 | USD | 0001388658-25-000028 |
| FY 2022Yearly · 2022-12-31 | Product | Non Contracted Third Party Payors | 24,133,000 | USD | 0001388658-25-000028 |
| FY 2021Yearly · 2021-12-31 | Product | Centers For Medicare And Medicaid | 44,529,000 | USD | 0001388658-24-000014 |
| FY 2021Yearly · 2021-12-31 | Product | Commercial Payors | 193,871,000 | USD | 0001388658-24-000014 |
| FY 2021Yearly · 2021-12-31 | Product | Healthcare Institutions | 57,496,000 | USD | 0001388658-24-000014 |
| FY 2021Yearly · 2021-12-31 | Product | Non Contracted Third Party Payors | 26,929,000 | USD | 0001388658-24-000014 |
| FY 2020Yearly · 2020-12-31 | Product | Centers For Medicare And Medicaid | 72,536,000 | USD | 0001388658-23-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Commercial Payors | 135,939,000 | USD | 0001388658-23-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Healthcare Institutions | 41,396,000 | USD | 0001388658-23-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Non Contracted Third Party Payors | 15,295,000 | USD | 0001388658-23-000007 |
| FY 2019Yearly · 2019-12-31 | Product | Centers For Medicare And Medicaid | 58,918,000 | USD | 0001388658-22-000020 |
| FY 2019Yearly · 2019-12-31 | Product | Commercial Payors | 101,845,000 | USD | 0001388658-22-000020 |
| FY 2019Yearly · 2019-12-31 | Product | Healthcare Institutions | 43,019,000 | USD | 0001388658-22-000020 |
| FY 2019Yearly · 2019-12-31 | Product | Non Contracted Third Party Payors | 10,770,000 | USD | 0001388658-22-000020 |
| FY 2018Yearly · 2018-12-31 | Product | Centers For Medicare And Medicaid | 40,482,000 | USD | 0001388658-21-000039 |
| FY 2018Yearly · 2018-12-31 | Product | Commercial Payors | 56,949,000 | USD | 0001388658-21-000039 |
| FY 2018Yearly · 2018-12-31 | Product | Healthcare Institutions | 37,399,000 | USD | 0001388658-21-000039 |
| FY 2018Yearly · 2018-12-31 | Product | Non Contracted Third Party Payors | 12,447,000 | USD | 0001388658-21-000039 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.